Clinical Trial

Białystok PLUS - Polish Longitudinal University Study

Study acronym: Bialystok+
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated March 15, 2023 (before its estimated December 2024 completion). Its status may not reflect the trial's current state.
Summary
The main goal of the study is to provide a unique multidimensional picture of the health of the population with simultaneous optimal standards of sampling, processing and storing of data and biomaterial that will allow discovering novel mechanisms in the development and progression of common civilization diseases. In the effect it will improve prevention, diagnosis and treatment.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2017-06-20; most recent amendment 2023-03-14.
Trial Details
NCT Number NCT03197363
Lead Sponsor Medical University of Bialystok
Collaborators: University Medicine Greifswald, City of Białystok, Marshall's Office of Podlaskie Voivodship
Conditions Cardiovascular Diseases, Diabetes, Neuro-Degenerative Disease, Obesity, Pulmonary Disease, Neoplastic Disease
Enrollment 10,000 participants
Start Date 2018-11-05
Primary Completion 2024-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2023-03-15